Exchange Traded Concepts, LLC Bridge Bio Pharma, Inc. Transaction History

Exchange Traded Concepts, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 15, 2024	BUY	$27.35 - $40.45 $2,817 - $4,166	103 New	103 $3,000
Q1 2022 Apr 26, 2022	SELL	$7.34 - $17.16 $144,840 - $338,618	-19,733 Closed	0 $0
Q4 2021 Jan 13, 2022	BUY	$11.38 - $53.41 $224,561 - $1.05 Million	19,733 New	19,733 $329,000
Q2 2021 Jul 30, 2021	SELL	$46.47 - $63.93 $6,226 - $8,566	-134 Closed	0 $0
Q1 2021 Apr 20, 2021	BUY	$55.47 - $72.35 $7,432 - $9,694	134 New	134 $8,000

291

171M

10.4M

2.37M

Ticker BBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 148,246,000
Market Cap $3.92B
Description
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...

Get notified when there are updates to the investment portfolio of Exchange Traded Concepts, LLC, based on Form 13F filings with the SEC.

Stay updated on Exchange Traded Concepts, LLC with notifications on news.